Oculis Holding AG (OCS) Assets Average (2023 - 2026)

Oculis Holding AG (OCS) recorded quarterly Assets Average of $303.4 million in Q1 2026, up 20.15% quarter-over-quarter from $252.5 million in Q4 2025, and up 66.49% on a YoY basis from $182.2 million in Q1 2025.

Oculis Holding AG (OCS) Assets Average (2023 - 2026) Analysis & Trends

Oculis Holding AG's Assets Average history runs 4 years deep, the most recent figure standing at $303.4 million for Q1 2026.

  • In Q1 2026, Assets Average rose 66.49% year-over-year to $303.4 million; the TTM figure through Mar 2026 stood at $303.4 million (up 66.49% YoY), while the FY2025 annual figure was $216.3 million, up 62.45% from the prior year.
  • Assets Average was $303.4 million for Q1 2026 at Oculis Holding AG, up from $252.5 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $303.4 million in Q1 2026 to a low of $121.0 million in Q1 2024.
  • Historically, Assets Average has averaged $182.4 million across 4 years, with a median of $149.2 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Assets Average climbed 0.82% in 2024, then surged 78.86% in 2025.
  • A 4-year view of Assets Average shows it stood at $137.4 million in 2023, then advanced by 2.72% to $141.2 million in 2024, then soared by 78.86% to $252.5 million in 2025, then climbed by 20.15% to $303.4 million in 2026.
  • The last three Assets Average figures came in at $303.4 million (Q1 2026), $252.5 million (Q4 2025), and $214.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - 33.42 Mn
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - 795.91 Mn
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 13.04 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 1.72 Bn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 40.89 Mn
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - 26.03 Mn
7 Psyence Biomedical 229.39 Bn 229.38 Bn - 10.06 Mn
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 26.06 Bn
9 Abivax 90.15 Bn 90.15 Bn - 660.38 Mn
10 Oculis Holding AG 8.23 Bn 7.92 Bn - 303.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 303.40 Mn
Dec 31, 2025 252.52 Mn
Sep 30, 2025 214.60 Mn
Jun 30, 2025 223.23 Mn
Mar 31, 2025 182.24 Mn
Dec 31, 2024 141.18 Mn
Sep 30, 2024 149.19 Mn
Jun 30, 2024 133.25 Mn
Mar 31, 2024 121.01 Mn
Dec 31, 2023 137.45 Mn
Sep 30, 2023 147.98 Mn